Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM3 | P20309 | 3/20 | 0.49 |
| ▸ | CHRM2 | P08172 | 2/20 | 0.47 |
| ▸ | CHRM1 | P11229 | 2/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.47 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6434933 | 0.98 | CHRM3 (0.50) | CHRM3CHRM2CHRM1ALDH1A1CHRM4 | |
| SCHEMBL27768710 | 0.78 | HPGD (0.45) | ALDH1A1 | |
| SCHEMBL28495717 | 0.75 | HPGD (0.53) | ALDH1A1 | |
| SCHEMBL1249246 | 0.75 | HPGD (0.53) | ALDH1A1 | |
| Piperilate SCHEMBL26493 | 0.74 | ALDH1A1 (0.78) | CHRM3CHRM2CHRM1ALDH1A1CHRM4 | |
| SCHEMBL29098438 | 0.74 | HPGD (0.52) | ALDH1A1 | |
| SCHEMBL2510973 | 0.73 | KMT2A (0.50) | ALDH1A1 | |
| Piperilate SCHEMBL1650954 | 0.73 | ALDH1A1 (0.76) | CHRM3CHRM2CHRM1ALDH1A1CHRM4 | |
| SCHEMBL11151698 | 0.72 | KCNN4 (0.35) | CHRM3ALDH1A1 | |
| SCHEMBL11878020 | 0.72 | CHRM3 (0.49) | CHRM3CHRM2CHRM1ALDH1A1CHRM4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1275645-B1 | LABELED COMPOUNDS FOR MEASURING THE FUNCTION OF THE MUSCARINIC ACETYLCHOLINE NERVOUS SYSTEM | HAMAMATSU PHOTONICS KK (JP) | 2007-02-28 | — | — | EP | claimed |
| US-6649142-B2 | Labeled compounds for measuring the function of the muscarinic acetylcholine nervous system | HAMAMATSU PHOTONICS K.K. (JP) | 2003-11-18 | — | — | US | claimed |
| US-20030113261-A1 | Labeled compounds for measuring the function of the muscarinic acetylcholine nervous system | HAMAMATSU PHOTONICS K.K. (JP) | 2003-06-19 | — | — | US | claimed |
| EP-1275645-A1 | LABELED COMPOUNDS FOR MEASURING THE FUNCTION OF THE MUSCARINIC ACETYLCHOLINE NERVOUS SYSTEM | HAMAMATSU PHOTONICS K. K. (JP) | 2003-01-15 | — | — | EP | claimed |
| WO-2015157138-A1 | ABUSE-DETERRENT CONTROLLED RELEASE FORMULATIONS | BANNER LIFE SCIENCES LLC (US) | 2015-10-15 | — | — | WO | disclosed |
| EP-1275645-B1 | LABELED COMPOUNDS FOR MEASURING THE FUNCTION OF THE MUSCARINIC ACETYLCHOLINE NERVOUS SYSTEM | HAMAMATSU PHOTONICS KK (JP) | 2007-02-28 | — | — | EP | disclosed |
| US-6649142-B2 | Labeled compounds for measuring the function of the muscarinic acetylcholine nervous system | HAMAMATSU PHOTONICS K.K. (JP) | 2003-11-18 | — | — | US | disclosed |
| US-20030113261-A1 | Labeled compounds for measuring the function of the muscarinic acetylcholine nervous system | HAMAMATSU PHOTONICS K.K. (JP) | 2003-06-19 | — | — | US | disclosed |
| EP-1275645-A1 | LABELED COMPOUNDS FOR MEASURING THE FUNCTION OF THE MUSCARINIC ACETYLCHOLINE NERVOUS SYSTEM | HAMAMATSU PHOTONICS K. K. (JP) | 2003-01-15 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030113261-A1 | Labeled compounds for measuring the function of the muscarinic acetylcholine nervous system | CHRM3, CHRM5, CHRM2 | CHRM3 1/4885CHRM2 3/4885CHRM1 6/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.